Rukiye Derin Atabey

Rukiye Derin Atabey

Auto-generated profile, based on publicly available information

Rukiye Derin Atabey

Department of Cardiovascular Surgery, Yuzuncu Yil University Faculty of Medicine, Van, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Acta Cardiologica
Verified
Journal Article
Closed access
NANesim Aladağ
Nesim Aladağ
RARukiye Derin Atabey
Rukiye Derin Atabey
To identify the potential cardiovascular risk factors associated with mortality in hospitalised COVID-19 patients. All consecutive patients admitted to intensive care unit (ICU) of our institute fo...



31 May 2026 in Eskisehir Medical Journal, Eskisehir City Hospital
Verified
Journal Article
Closed access
AKAlper Selim Kocaoglu
Alper Selim Kocaoglu
IKİbRahim Çağrı Kaya
İbRahim Çağrı Kaya
MÖMerih Özbayburt
Merih Özbayburt
ADAbdurrahman Demirel
Abdurrahman Demirel
RARukiye Derin Atabey
Rukiye Derin Atabey
SBSinan Balçın
Sinan Balçın
Introduction: Postoperative atrial fibrillation (POAF) is a common complication after coronary artery bypass grafting (CABG), with incidence rates reported between 20% and 40%. Pain and hypoxia related to intercostal chest tube placement may play a role in the development of POAF. This study sought to compare the impacts of midaxillary intercostal versus subxiphoid chest tube placement on the development of postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass. Methods: A retrospective, single-center study was performed involving 675 patients who underwent isolated coronary artery bypass grafting (CABG) utilizing the left internal mammary artery (LIMA) from January 2021 to March 2025. Patients were categorized into two groups: Group 1 (n=442) underwent midaxillary intercostal drainage, while Group 2 (n=233) received subxiphoid drainage. The two groups were similar in terms of demographic and perioperative factors. The primary outcome was the occurrence of POAF; secondary outcomes encompassed postoperative pain scores, oxygenation metrics, and drainage efficacy. Results: POAF manifested in 34.2% of Group 1 and 18% of Group 2 (p<0.05). Subxiphoid drainage was correlated with elevated postoperative arterial pO₂ (82 vs. 74 mmHg; p=0.042), reduced pCO₂ (38 vs. 42 mmHg; p=0.025), and diminished pain scores (VAS 5 vs. 8; p=0.002). Group 2 also used a lot less pain medicine. There was no significant difference in the effectiveness of drainage or the rates of pleural effusion. Conclusion: Subxiphoid chest tube placement following CABG is linked to diminished pain, enhanced oxygenation, and markedly lower rates of postoperative atrial fibrillation (POAF) in comparison to intercostal placement. This method is a simple, flexible way to improve postoperative results, and it should be included in CABG surgical protocols.

1 February 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
RARukiye Derin Atabey
Rukiye Derin Atabey
NANesim Aladağ
Nesim Aladağ
AŞAbdulcebbar Şipal
Abdulcebbar Şipal
TATayyar Akbulut
Tayyar Akbulut
ZDZeki Dogan
Zeki Dogan
MOMahmut ÖzDemir
Mahmut ÖzDemir
OBJECTIVES: Cardiovascular diseases are also considered to increase the risk of death in COVID-19 patients. However, real-world data concerning the risk factors for death in patients with severe COVID-19 still remain vague. This study aimed to identify the potential risk factors associated with mortality in severe COVID-19 patients. METHODS: All consecutive patients admitted to the intensive care unit (ICU) of our institute for COVID-19 for severe COVID-19 pneumonia from April 1, 2020 to July 20, 2020 were included in the analysis. Patient characteristics, including complete medical history and comorbid diseases, blood test results during admission and on day 7, and clinical characteristics were compared between survivors and nonsurvivors. RESULTS: There was no significant difference between survivors and nonsurvivors regarding age, gender, and preexisting cardiovascular diseases. Moreover, the rate of the medications including angiotensin-converting enzyme (ACE) inhibitor and angiotensin receptor blockers did not differ between survivors and nonsurvivors. The peak C-reactive protein (CRP), procalcitonin, fibrinogen, and D-dimer levels and the rate for chronic renal failure were significantly higher in nonsurvivors compared with survivors. Intubated patients had a higher risk of death than the others had. CONCLUSIONS: This study failed to demonstrate a significant difference in preexisting cardiovascular diseases and cardiovascular medications between survivors and nonsurvivors who were admitted to ICU for severe COVID-19. Our findings indicate that the presence of chronic renal failure, a high peak ferritin concentration, and the need for invasive mechanical ventilation appear predictive for mortality. We propose that these risk factors should be taken into account in defining the risk status of severe COVID-19 patients admitted to the ICU.